Author

Martina Antoniolli

LMU KlinikumORCID 0000-0003-2720-9886Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Assay:scRNA-seq· 1 Research Focus:trajectory inference· 1

Frequent Co-Authors

Carmen S. M. Yong· 1 shared Carolin Dorothea StrobliD· 1 shared Christina LudwigiD· 1 shared Deepak BarariaiD· 1 shared Emilio YángüeziD· 1 shared Heinrich LeonhardtiD· 1 shared Helmut BlumiD· 1 shared Johannes Adrian HildebrandiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Carmen S. M. Yong

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsbioRxivPreprintMar 9, 2026

Performance of the 10X Genomics Flex Single-Cell Sequencing Assay and its Application to Overcome Challenges in Clinical Trial Samples

Martina Antoniolli, Llucia Albertí Servera, Kerstin Paetzold…·Steffen Dettling

The paper compares scRNA-seq protocols for clinical trial samples, finding that GEM-X Flex with chop-fix outperforms standard protocols and snRNA-seq in fixed tissue and FFPE blocks.

DOI 10.64898/2026.03.06.710062

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologyCell Death and DifferentiationPeer-reviewedJan 22, 2025

ARID1A Mutations Protect Follicular Lymphoma from FAS-dependent Immune Surveillance by Reducing RUNX3/ETS1-Driven FAS-Expression

Martina Antoniolli, Maria Solovey, Johannes Adrian Hildebrand…·Oliver Weigert

This study identifies ARID1A mutations in follicular lymphoma that reduce FAS expression, enabling immune evasion by disrupting RUNX3/ETS1 regulation.

11 citationstop 2%

humanbulk RNA-seq

𝕏 PostBluesky